Home About us Articles Multimedia Search Instructions Login 
5 years IF: 1.036 (® Thomson Reuters)
IF 2016: 1.064 (® Thomson Reuters)
Total Cites: 7140
Follow Us
Follow Us
  • Users Online: 477
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model

Peng Hong-Ling, Yi Yi-Fang, Zhou Shun-Ke, Xie Si-Si, Zhang Guang-Sen

Year : 2015| Volume: 128| Issue : 22 | Page no: 3050-3054

   This article has been cited by
1 Etiology and Genetics of Congenital Vascular Lesions
Angela Queisser,Laurence M. Boon,Miikka Vikkula
Otolaryngologic Clinics of North America. 2018; 51(1): 41
[Pubmed]  [Google Scholar] [DOI]
2 Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review
Ashleigh A. Halderman,Matthew W. Ryan,Christopher Clark,Raj Sindwani,Douglas D. Reh,David M. Poetker,Rosangela Invernizzi,Bradley F. Marple
International Forum of Allergy & Rhinology. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study
Jia Fang,Xiaomeng Chen,Bijun Zhu,Haibo Ye,Weitian Zhang,Jian Guan,Kaiming Su
Otolaryngology-Head and Neck Surgery. 2017; 157(2): 217
[Pubmed]  [Google Scholar] [DOI]
4 Update March 2016
Francine Blei
Lymphatic Research and Biology. 2016; 14(1): 40
[Pubmed]  [Google Scholar] [DOI]


Read this article